Modulation of gene expression by combination therapy
US6953783B1 · kind B1 · utility
4Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 1999 |
| Grant date | Oct 11, 2005 |
| Priority date | — |
| Expiry date | Oct 19, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the modulation of gene expression. In particular, the invention relates to compositions comprising antisense oligonucleotides which inhibit expression of a gene in operable association with protein effectors of a product of that gene, and methods of using the same.In addition, the invention relates to the modulation of mammalian gene expression regulated by methylation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.